Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein

Arthritis and Rheumatism

Volumn 54, Issue 1, 2006, Pages 325-335

  Rodriguez, Wilfredo ^a   Mold, Carolyn ^a   Marnell, Lorraine L ^a   Hutt, Julie ^b   Silverman, Gregg J ^c   Tran, Dao ^d   Du Clos, Terry W ^a,e  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Biomedical Research Institute of New Mexico   (United States)

^e VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AUTOANTIBODY; AUTOANTIGEN; BASILIXIMAB; C REACTIVE PROTEIN; DNA ANTIBODY; DOUBLE STRANDED DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE COURSE; DOSE TIME EFFECT RELATION; FEMALE; GLOMERULONEPHRITIS; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; IMMUNE COMPLEX NEPHRITIS; INTERSTITIAL NEPHRITIS; LYMPHADENOPATHY; MACROPHAGE ACTIVATION; MORTALITY; MOUSE; NEPHRITIS; NONHUMAN; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEINURIA; T LYMPHOCYTE ACTIVATION;

ANIMALS; C-REACTIVE PROTEIN; FEMALE; INJECTIONS; MICE; MICE, INBRED MRL LPR; NEPHRITIS; REMISSION INDUCTION;

EID: 31044446853     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21556     Document Type: Article

References (40)

1. Du Clos TW. Function of C-reactive protein. Ann Med 2000;32:274-8.
2. Du Clos TW. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens. Mol Biol Rep 1996;23:253-60.
3. Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol 2001;38:189-97.
4. Gabay C, Roux-Lombard P, de Moerloose P, Dayer JM, Vischer T, Guerne PA. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol 1993;20:815-21.
5. Du Clos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res 2004;30:261-78.
6. Heuertz RM, Dongyuan X, Samols D, Webster RO. Inhibition of C5a des Arg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein. Am J Physiol 1994;266:L649-54.
7. Heuertz RM, Piquette CA, Webster RO. Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am J Pathol 1993;142:319-28.
8. Xia D, Samols D. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci USA 1997;94:2575-80.
9. Mold C, Rodriguez W, Rodic-Polic B, Du Clos TW. C-reactive protein mediates protection from lipopolysaccharide through interactions with FcyR. J Immunol 2002;169:7019-25.
10. Szalai AJ, Nataf S, Hu XZ, Barnum SR. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J Immunol 2002;168:5792-7.
11. Gershov D, Kim S, Brot N, Elkon KB. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 2000;192:1353-63.
12. Mold C, Baca R, Du Clos TW. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcγ receptors. J Autoimmun 2002;19:147-54.
13. Du Clos TW, Zlock LT, Hicks PS, Mold C. Decreased autoantibody levels and enhanced survival of (NZB × NZW) F1 mice treated with C-reactive protein. Clin Immunol Immunopathol 1994;70:22-7.
14. 1 mice expressing a human C-reactive protein transgene. Arthritis Rheum 2003;48:1602-11.
15. Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis Rheum 2005;52:642-50.
16. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985;37:269-391.
17. Du Clos TW. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J Immunol 1989;143:2553-9.
18. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994;174:83-93.
19. Du Clos TW, Volzer MA, Hahn FF, Xiao R, Mold C, Searles RP. Chromatin clearance in C57B1/10 mice: interaction with heparan sulphate proteoglycans and receptors on Kupffer cells. Clin Exp Immunol 1999;117:403-11.
20. Oldenhove G, de Heusch M, Urbain-Vansanten G, Urbain J, Maliszewski C, Leo O, et al. CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J Exp Med 2003;198:259-66.
21. Rubin RL. Enzyme-linked immunosorbent assay for anti-DNA and antihistone antibodies. In: Rose NR, Friedman H, Fahey JL, editors. Manual of clinical laboratory immunology. Washington: ASM; 1986. p. 744-9.
22. Kikawada E, Lenda DM, Kelley VR. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFNγ expression, and diminishes systemic pathology. J Immunol 2003;170:3915-25.
23. Smeenk RJ, Brinkman K, van den Brink HG, Westgeest AA. Reaction patterns of monoclonal antibodies to DNA. J Immunol 1988;140:3786-92.
24. McHugh RS, Shevach EM. Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 2002;168:5979-83.
25. Du Clos TW. C-reactive protein as a regulator of autoimmunity and inflammation [editorial]. Arthritis Rheum 2003;48:1475-7.
26. Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 2005;202:321-31.
27. Zhou T, Bluethmann H, Eldridge J, Berry K, Mountz JD. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice: clues from a T cell receptor β transgenic mouse. J Immunol 1993;150:3651-67.
28. Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med 1999;190:1813-24.
29. Walport MJ. Lupus, DNase and defective disposal of cellular debris. Nat Genet 2000;25:135-6.
30. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB. Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses. Ann N Y Acad Sci 2003;987:68-78.
31. Ehrenstein MR, Cook HT, Neuberger MS. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med 2000;191:1253-8.
32. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A 2000;97:1184-9.
33. Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology 2002;205:395-406.
34. Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998;279:1052-4.
35. Balomenos D, Rumold R, Theofilopoulos AN. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest 1998;101:364-71.
36. Heuertz RM, Xia D, Samols D, Webster RO. Inhibition of C5a des Arg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein. Am J Physiol 1994;266:L649-54.
37. Baltz ML, Rowe IF, Pepys MB. In vivo turnover studies of C-reactive protein. Clin Exp Immunol 1985;59:243-50.
38. Hutchinson WL, Noble GE, Hawkins PN, Pepys MB. The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. J Clin Invest 1994;94:1390-6.
39. Carvalho-Pinto CE, Garcia MI, Mellado M, Rodriguez-Frade JM, Martin-Caballero J, Flores J, et al. Autocrine production of IFNγ by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice. J Immunol 2002;169:1058-67.
40. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.